One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year
A single dose of an experimental drug from Eli Lilly & Co. cut by 94% a risk factor
2023-11-13 09:27
Astellas Pharma Secures US FDA Approval for Izervay
The US Food and Drug Administration approved Astellas Pharma Inc.’s Izervay for the treatment of age-related macular degeneration,
2023-08-05 10:19